First Obesity Medicine Appointment: What to Expect and Bring
An adult considering a first obesity medicine appointment may hesitate before booking. They may wonder whether the visit will focus […]
An adult considering a first obesity medicine appointment may hesitate before booking. They may wonder whether the visit will focus […]
What if the better question isn't “Which drug wins?”, but “Which outcome matters most for you, and what trade-offs are
Which medication is “better,” semaglutide or tirzepatide, depends on more than the larger number on a trial chart. The clinically
Tirzepatide is a once-weekly injectable medication FDA-approved as Mounjaro for adults with type 2 diabetes and as Zepbound for chronic
Gastrointestinal symptoms are the most common Zepbound side effects. In the key trial, 78.9% to 81.8% of participants receiving tirzepatide